HMGA2: High Mobility Group AT-Hook 2
Architectural Transcription Factor in Growth, Development, and Oncogenesis
Gene Information Card
| Symbol | HMGA2 |
|---|---|
| Full Name | High Mobility Group AT-Hook 2 |
| Gene Type | Protein coding |
| Chromosomal Location | 12q14.3 |
| NCBI Gene ID | 8091 ncbi.nlm.nih.gov/gene/8091 |
| Ensembl ID | ENSG00000149948 |
| UniProt ID | P52926 |
| OMIM ID | 600698 |
| HGNC ID | 5009 |
| Aliases | HMGIC, LIPO, BABL, HMGI-C, STQTL9 |
Description
HMGA2 encodes a member of the high mobility group (HMG) protein family. The protein contains AT-hook DNA-binding domains and functions as an architectural transcription factor, regulating chromatin structure and gene expression. It plays critical roles in growth, development, and cell proliferation. Chromosomal rearrangements involving HMGA2 are frequently associated with benign mesenchymal tumors such as lipomas, uterine leiomyomas, and pituitary adenomas. Overexpression or truncation of HMGA2 is implicated in various cancers and growth disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Lipoma | HMGA2 rearrangements (e.g., 12q14.3 breaks) lead to aberrant expression or truncated protein, promoting adipocyte proliferation. | OMIM #600698; COSMIC; ClinVar |
| Pituitary Adenoma | HMGA2 overexpression or rearrangement drives tumorigenesis in somatotroph cells. | OMIM #600698; NCBI Gene |
| Uterine Leiomyoma | HMGA2 rearrangements (e.g., t(12;14)) result in dysregulation, contributing to smooth muscle tumor formation. | OMIM #600698; ClinVar |
| Breast Cancer | HMGA2 overexpression correlates with poor prognosis and metastasis. | COSMIC; NCBI Gene |
| Lung Cancer | HMGA2 amplification or overexpression promotes epithelial-mesenchymal transition and invasion. | COSMIC; NCBI Gene |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 5.2 | Medium |
| Uterus | 3.8 | Low |
| Pituitary gland | 2.1 | Low |
| Lung | 1.5 | Low |
| Breast | 1.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HeLa | 4.5 | Cervical cancer cell line |
| A549 | 3.2 | Lung adenocarcinoma cell line |
| MCF7 | 2.8 | Breast cancer cell line |
| HT-29 | 1.9 | Colorectal adenocarcinoma cell line |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1-? rearrangements | Structural variant | Common in lipomas | Disrupts 3' UTR, leading to overexpression or truncated protein |
| p.Thr20Ala | Missense | Rare | Unknown functional effect |
| Amplification | Copy number gain | Frequent in lung and breast cancers | Increased HMGA2 expression |
Mutation functional classification
Loss of Function (LOF)
Not commonly reported; HMGA2 is primarily oncogenic via gain-of-function or overexpression.
Gain of Function (GOF)
Rearrangements leading to overexpression or truncated protein lacking the C-terminal regulatory domain enhance transcriptional activity and promote proliferation.
Dominant Negative (DN)
Truncated HMGA2 isoforms may interfere with wild-type protein function, though dominant-negative effects are not well established.
View complete mutation data:
Gene Ontology (GO)
Pathways
• PI3K-Akt signaling pathway
• MAPK signaling pathway
• TGF-beta signaling pathway
• Transcriptional misregulation in cancer
Protein Summary
HMGA2 is a small nuclear protein (109 amino acids) with three AT-hook DNA-binding motifs that bind to the minor groove of AT-rich DNA sequences. It does not have intrinsic transcriptional activity but alters chromatin architecture to facilitate or repress transcription of target genes. The protein is highly expressed during embryonic development and in many cancers, but is low or absent in most normal adult tissues. Post-translational modifications include phosphorylation and acetylation, which modulate its DNA-binding affinity and stability.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| HMGA2 Knockout HEK293 Cell Line | EDJ-KQ924 | Human | 8091 | Details Get a Quote |
| HMGA2 Knockout HCT 116 Cell Line | EDJ-KQ18562 | Human | 8091 | Details Get a Quote |
| HMGA2 Knockout A-549 Cell Line | EDJ-KQ19891 | Human | 8091 | Details Get a Quote |
| HMGA2 Knockout HeLa Cell Line | EDJ-KQ19893 | Human | 8091 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records